Short-term, low-dose use for severe pain is reasonable, but chronic NSAID use during BPC-157 treatment is questionable
How it works BPC-157 appears to act largely by promoting angiogenesis the growth of new blood vessels into damaged tissue and by upregulating growth-hormone receptor expression in injured tissue, which sensitizes the area to the body's own repair signals
For someone starting at 220 pounds, that translates to roughly 46 pounds of total weight reduction over a standard treatment course
Desired Dose (mg) Supports 30+ peptides including GLP-1s (Tirzepatide, Retatrutide, Semaglutide), BPC-157, Semax, Selank, MOTS-c, Tesamorelin, NAD+, and peptide blends (BPC-157 + TB-500, GLOW, KLOW), with BAC water guidance to minimize injection site irritation
Additives : Antioxidants or reducing agents (e.g., DTT) may help, but use cautiously as they can interfere with some assays
Some people describe it as finally feeling rested after a good night's sleep